Axitinib is a tyrosine kinase inhibitor targeted against vascular endothelial growth factor receptors (VEGFRs) that is used to treat renal cell carcinoma, which is its sole approved indication, worldwide.
|Targeted therapies (ATC: L01X)|
(Suffix: -mab. ATC: XC)
|Protein kinase inhibitors|
Ad blocker interference detected!
Wikia is a free-to-use site that makes money from advertising. We have a modified experience for viewers using ad blockers
Wikia is not accessible if you’ve made further modifications. Remove the custom ad blocker rule(s) and the page will load as expected.